4017 · 06/08/2025 08:10:27 · Announcement #89312 · View on Saudi Exchange

Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Interim Financial results for the Period Ending on 2025-06-30 ( Six Months )

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	811.84	654.04	24.126	701.02	15.808
Gross Profit (Loss)	180.62	161.87	11.583	176.14	2.543
Operational Profit (Loss)	81.61	77.19	5.726	76.98	6.014
Net profit (Loss)	68.16	42.86	59.029	67.35	1.202
Total Comprehensive Income	68.16	42.86	59.029	67.35	1.202
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	1,512.86	1,334.38	13.375
Gross Profit (Loss)	356.75	350.46	1.794
Operational Profit (Loss)	158.59	182.29	-13.001
Net profit (Loss)	135.52	103.56	30.861
Total Comprehensive Income	135.52	103.56	30.861
Total Shareholders Equity (after Deducting Minority Equity)	3,034.45	2,795.93	8.53
Profit (Loss) per Share	0.67	0.59
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Revenue reached SAR 811.8 million in 2Q25, a 24.1% year-on-year increase, mainly due to patients served reaching 465 thousand (16% more from prior year quarter), an improved business mix and the revenue from the ambulatory project delivered in Hajj period.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net Profit rose 59% YoY in 2Q25 to SAR 68.2 million, driven by underlying business growth across segments, lower finance costs, and higher finance income. Similarly, Profits attributable to Shareholders grew 73% year-on-year to SAR 82.1 million. Taking into consideration the dilution effect of the 30M newly issued shares in the IPO, EPS read SAR 0.67 in 1H25, up 14% from 1H24.

EBITDA reached SAR 129.1 million in 2Q25, growing by 11.2% year-on-year despite the ramp-up effect from the newly opened Madinah Hospital, reflecting larger billing volumes and underlying cost control.The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is Revenue in 2Q-2025 was SAR 811.8 million, growing by 15.8% from 1Q-2025, supported by a rebound in patient volumes post Ramadan and Eid seasonality and improvement in business mix, in addition to the Group's delivery of the Hajj ambulatory tender in 2Q-2025.The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Net profit for 2Q-2025 was SAR 68.2 million, increasing by 1.2% compared to 1Q-2025 as a result of growth in patients served despite the fact that the Haj contract was at a lower margin compared to our main business and the operate and manage of Namira Hospital during the Haj period on a Corporate Social Responsibility basis.The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is Revenue for 1H-2025 reached SAR 1,512.9 million, a 13.4% year-on-year increase, as a result of higher patient volumes across all business and an improved business mix, in addition to the Group's delivery of the Hajj ambulatory services in 2Q-2025.The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net Profit in 1H-2025 reached SAR 135.5 million, up 30.9% year-on-year, driven by overall growth in business and improved capital structure.

EBITDA reached SAR 250.2 million in 1H 2025, 3.3% lower than the prior year, reflecting the impact of pre-operating and ramp-up expenses of our newly opened hospital in Madinah.Statement of the type of external auditor's report Unmodified conclusionComment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) NAReclassification of Comparison Items Certain comparative figures have been reclassified, wherever considered necessary, for the purpose of comparison and better presentation.Additional Information NAAttached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.